iSoft win UK contract with Lorenzo

Peter Dinham
Friday, 06 November 2009 08:58

IT Industry - Deals

Australia's largest listed health IT company, iSOFT, has added to its UK healthcare industry client base with  the implementation of the latest version of its Lorenzo electronic patient record solution at NHS Bury Primary Care Trust (PCT) in Lancashire.

Gary Cohen, iSOFT’s executive chairman and CEO said today Lorenzo regional care 1.9 had gone live with NHS Bury this month and is being used by the organisation for referral and caseload management as well as inpatient and outpatient functionality. The system supports almost 600 community-based clinical and administrative users working across two wards and 1,200 clinics, and the trust has plans to introduce clinical functionality in the coming months by using assessment functionality for orthopaedics and dietetics.

According to Cohen, “Bury PCT demonstrates a significant step forward for Lorenzo’s strategic role within the National Programme for IT. The implementation teams have shown tenacity and determination to deliver a successful go-live and we are looking forward to further go-lives with this Trust, and a number of others, in the near future.”

iSOFT's UK and Ireland managing director, Stevens, says the company remains committed to actively working with partner CSC on the delivery of Lorenzo Regional Care under the North, Midlands and East Programme for IT.

“The Bury Trust go-live is a particularly important achievement, both for iSOFT as well the National Programme, because this latest version of Lorenzo takes the efficient provision of healthcare in England to a new level. We will be closely monitoring the deployment at Bury over the coming weeks to ensure the system works well as staff continue to use this on a daily basis. Looking beyond the success at Bury, iSOFT continues to actively support both CSC and NHS Connecting for Health in achieving the goals of the NPfIT and core IT strategy by continuing to deliver Lorenzo to the contracted regions in England.”